speb/financial-data huggingface dataset:
SYL.AX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 236161000.00
SYL.AX cash_flow (annual, 2025-06-30) — Other Cash Receiptsfrom Operating Activities: 6456000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Current Assets: 45216000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 45216000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Current Borrowings: 2393000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 2393000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Current Liabilities: 53473000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 53473000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Equity Adjustments: -195974000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -195974000.00
SYL.AX income_statement (annual, 2025-06-30) — Other Income Expense: 9841000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 13211000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 13211000.00
SYL.AX income_statement (annual, 2025-06-30) — Other Non Operating Income Expenses: 8988000.00
SYL.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 29761000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Payable: 64782000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Payable: 64782000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Properties: 33344000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Properties: 33344000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Other Receivables: 45522000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 45522000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Payables: 141953000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Payables: 141953000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 141953000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 141953000.00
SYL.AX cash_flow (annual, 2025-06-30) — Paymentsto Suppliersfor Goodsand Services: -844241000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 17396000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 17396000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Prepaid Assets: 9708000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 9708000.00
SYL.AX income_statement (annual, 2025-06-30) — Pretax Income: 54146000.00
SYL.AX cash_flow (annual, 2025-06-30) — Purchase Of Business: -17387000.00
SYL.AX cash_flow (annual, 2025-06-30) — Purchase Of PPE: -60918000.00
SYL.AX cash_flow (annual, 2025-06-30) — Receiptsfrom Customers: 958504000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Receivables: 112400000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Receivables: 112400000.00
SYL.AX income_statement (annual, 2025-06-30) — Reconciled Cost Of Revenue: 697126000.00
SYL.AX income_statement (annual, 2025-06-30) — Reconciled Depreciation: 29854000.00
SYL.AX cash_flow (annual, 2025-06-30) — Repayment Of Debt: -92928000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Retained Earnings: 73417000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 73417000.00
SYL.AX income_statement (annual, 2025-06-30) — Salaries And Wages: 70738000.00
SYL.AX cash_flow (annual, 2025-06-30) — Sale Of PPE: 9325000.00
SYL.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 70738000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Share Issued: 236161000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Share Issued: 236161000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Stockholders Equity: 170515000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 170515000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Tangible Book Value: 133525000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 133525000.00
SYL.AX income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SYL.AX income_statement (annual, 2025-06-30) — Tax Provision: 18258000.00
SYL.AX income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.34
SYL.AX cash_flow (annual, 2025-06-30) — Taxes Refund Paid Direct: -20347000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Assets: 557278000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 557278000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 170515000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 170515000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Debt: 155940000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Debt: 155940000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 170515000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 170515000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 386763000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 386763000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 220184000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 220184000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 126000000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 126000000.00
SYL.AX income_statement (annual, 2025-06-30) — Total Other Finance Cost: 959000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Tradeand Other Payables Non Current: 1665000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 1665000.00
SYL.AX balance_sheet (annual, 2025-06-30) — Working Capital: 76331000.00
SYL.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 76331000.00
SYM cash_flow (annual, 2021-09-30) — Capital Expenditure Reported: 0.00
SYM cash_flow (annual, 2021-09-30) — Net Preferred Stock Issuance: 0.00
SYM income_statement (annual, 2021-09-30) — Otherunder Preferred Stock Dividend: -122314000.00
SYM balance_sheet (annual, 2021-09-30) — Preferred Securities Outside Stock Equity: 836260000.00
SYM income_statement (annual, 2021-09-30) — Preferred Stock Dividends: 32919000.00
SYM cash_flow (annual, 2021-09-30) — Preferred Stock Issuance: 0.00
SYM balance_sheet (annual, 2021-09-30) — Prepaid Assets: 6366000.00
SYM balance_sheet (annual, 2021-09-30) — Total Tax Payable: 18405000.00
SYM income_statement (annual, 2022-09-30) — +Operating Expense: 240022000.00
SYM income_statement (annual, 2022-09-30) — +Total Revenue: 593312000.00
SYM balance_sheet (annual, 2022-09-30) — Accounts Payable: 68448000.00
SYM balance_sheet (annual, 2022-09-30) — Accounts Receivable: 3412000.00
SYM balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -23844000.00
SYM balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 1295991000.00
SYM income_statement (annual, 2022-09-30) — Basic Average Shares: 54086381.00
SYM income_statement (annual, 2022-09-30) — Basic EPS: -0.13
SYM cash_flow (annual, 2022-09-30) — Beginning Cash Position: 156634000.00
SYM cash_flow (annual, 2022-09-30) — Capital Expenditure: -17950000.00
SYM cash_flow (annual, 2022-09-30) — Capital Expenditure Reported: 0.00
SYM balance_sheet (annual, 2022-09-30) — Capital Stock: 56000.00
SYM balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 353457000.00
SYM balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Short Term Investments: 353457000.00
SYM cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 362448000.00
SYM cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -17950000.00
SYM cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: -148247000.00
SYM cash_flow (annual, 2022-09-30) — Change In Account Payable: 41528000.00
SYM cash_flow (annual, 2022-09-30) — Change In Accrued Expense: 37898000.00
SYM cash_flow (annual, 2022-09-30) — Change In Inventory: -60559000.00
SYM cash_flow (annual, 2022-09-30) — Change In Other Current Assets: 49000.00
SYM cash_flow (annual, 2022-09-30) — Change In Other Current Liabilities: 3908000.00
SYM cash_flow (annual, 2022-09-30) — Change In Other Working Capital: 51712000.00
SYM cash_flow (annual, 2022-09-30) — Change In Payable: 41528000.00
SYM cash_flow (annual, 2022-09-30) — Change In Payables And Accrued Expense: 79426000.00
SYM cash_flow (annual, 2022-09-30) — Change In Prepaid Assets: -121143000.00
SYM cash_flow (annual, 2022-09-30) — Change In Receivables: -508000.00
SYM cash_flow (annual, 2022-09-30) — Change In Working Capital: -47115000.00
SYM cash_flow (annual, 2022-09-30) — Changes In Account Receivables: -508000.00
SYM cash_flow (annual, 2022-09-30) — Changes In Cash: 196251000.00
SYM balance_sheet (annual, 2022-09-30) — Common Stock: 56000.00
SYM balance_sheet (annual, 2022-09-30) — Common Stock Equity: 7184000.00
SYM cash_flow (annual, 2022-09-30) — Common Stock Issuance: 384672000.00
SYM income_statement (annual, 2022-09-30) — Cost Of Revenue: 493665000.00
SYM balance_sheet (annual, 2022-09-30) — Current Accrued Expenses: 47312000.00
SYM balance_sheet (annual, 2022-09-30) — Current Assets: 605398000.00
SYM balance_sheet (annual, 2022-09-30) — Current Deferred Assets: 29150000.00
SYM balance_sheet (annual, 2022-09-30) — Current Deferred Liabilities: 394244000.00
SYM balance_sheet (annual, 2022-09-30) — Current Deferred Revenue: 394244000.00
SYM balance_sheet (annual, 2022-09-30) — Current Liabilities: 522957000.00
SYM cash_flow (annual, 2022-09-30) — Deferred Income Tax: 0.00
SYM cash_flow (annual, 2022-09-30) — Deferred Tax: 0.00
SYM cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 5989000.00
SYM cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 5989000.00
SYM income_statement (annual, 2022-09-30) — Diluted Average Shares: 54086381.00
SYM income_statement (annual, 2022-09-30) — Diluted EPS: -0.13
SYM income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: -6863000.00
SYM income_statement (annual, 2022-09-30) — EBIT: -140375000.00
SYM income_statement (annual, 2022-09-30) — EBITDA: -134386000.00
SYM income_statement (annual, 2022-09-30) — Earnings From Equity Interest Net Of Tax: 0.00
SYM cash_flow (annual, 2022-09-30) — Effect Of Exchange Rate Changes: 572000.00
SYM cash_flow (annual, 2022-09-30) — End Cash Position: 353457000.00
SYM cash_flow (annual, 2022-09-30) — Financing Cash Flow: 362448000.00
SYM balance_sheet (annual, 2022-09-30) — Finished Goods: 2901000.00
SYM cash_flow (annual, 2022-09-30) — Free Cash Flow: -166197000.00
SYM balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: -2294000.00
SYM balance_sheet (annual, 2022-09-30) — Goodwill And Other Intangible Assets: 650000.00
SYM balance_sheet (annual, 2022-09-30) — Gross PPE: 48722000.00
SYM income_statement (annual, 2022-09-30) — Gross Profit: 99647000.00
SYM balance_sheet (annual, 2022-09-30) — Inventory: 91900000.00
SYM balance_sheet (annual, 2022-09-30) — Invested Capital: 7184000.00
SYM cash_flow (annual, 2022-09-30) — Investing Cash Flow: -17950000.00
SYM cash_flow (annual, 2022-09-30) — Issuance Of Capital Stock: 384672000.00
SYM balance_sheet (annual, 2022-09-30) — Leases: 2904000.00
SYM balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 45818000.00
SYM balance_sheet (annual, 2022-09-30) — Minority Interest: 61756000.00
SYM income_statement (annual, 2022-09-30) — Minority Interests: 60092000.00
SYM cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: 384672000.00
SYM cash_flow (annual, 2022-09-30) — Net Foreign Currency Exchange Gain Loss: 25000.00
SYM income_statement (annual, 2022-09-30) — Net Income: -78997000.00
SYM income_statement (annual, 2022-09-30) — Net Income Common Stockholders: -6863000.00
SYM income_statement (annual, 2022-09-30) — Net Income Continuous Operations: -139089000.00
SYM income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: -78997000.00
SYM income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: -78997000.00
SYM cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: -139089000.00
SYM income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: -139089000.00
SYM cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 0.00
SYM cash_flow (annual, 2022-09-30) — Net Other Financing Charges: -300000000.00
SYM balance_sheet (annual, 2022-09-30) — Net PPE: 24878000.00
SYM cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -17950000.00
SYM cash_flow (annual, 2022-09-30) — Net Preferred Stock Issuance: 0.00
SYM balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 6534000.00
SYM balance_sheet (annual, 2022-09-30) — Non Current Deferred Liabilities: 31465000.00
SYM balance_sheet (annual, 2022-09-30) — Non Current Deferred Revenue: 31465000.00
SYM income_statement (annual, 2022-09-30) — Normalized EBITDA: -134386000.00
SYM income_statement (annual, 2022-09-30) — Normalized Income: -78997000.00
SYM cash_flow (annual, 2022-09-30) — Operating Cash Flow: -148247000.00
SYM cash_flow (annual, 2022-09-30) — Operating Gains Losses: 4123000.00
SYM income_statement (annual, 2022-09-30) — Operating Income: -140375000.00
SYM income_statement (annual, 2022-09-30) — Operating Revenue: 593312000.00
SYM balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 57718836.00
SYM balance_sheet (annual, 2022-09-30) — Other Current Assets: 25663000.00
SYM balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: -2294000.00
SYM income_statement (annual, 2022-09-30) — Other Income Expense: 1286000.00
SYM balance_sheet (annual, 2022-09-30) — Other Intangible Assets: 650000.00
SYM balance_sheet (annual, 2022-09-30) — Other Non Current Assets: 337000.00
SYM balance_sheet (annual, 2022-09-30) — Other Non Current Liabilities: 7901000.00
SYM income_statement (annual, 2022-09-30) — Other Non Operating Income Expenses: 1286000.00
SYM balance_sheet (annual, 2022-09-30) — Other Receivables: 101816000.00
SYM balance_sheet (annual, 2022-09-30) — Other Short Term Investments: 0.00
SYM income_statement (annual, 2022-09-30) — Otherunder Preferred Stock Dividend: -72134000.00
SYM balance_sheet (annual, 2022-09-30) — Payables: 81401000.00
SYM balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 128713000.00
SYM balance_sheet (annual, 2022-09-30) — Preferred Securities Outside Stock Equity: 0.00
SYM cash_flow (annual, 2022-09-30) — Preferred Stock Issuance: 0.00
SYM balance_sheet (annual, 2022-09-30) — Prepaid Assets: 25663000.00
SYM income_statement (annual, 2022-09-30) — Pretax Income: -139089000.00
SYM cash_flow (annual, 2022-09-30) — Proceeds From Stock Option Exercised: 277776000.00
SYM balance_sheet (annual, 2022-09-30) — Properties: 0.00
SYM cash_flow (annual, 2022-09-30) — Provisionand Write Offof Assets: 987000.00
SYM cash_flow (annual, 2022-09-30) — Purchase Of Investment: 0.00
SYM cash_flow (annual, 2022-09-30) — Purchase Of PPE: -17950000.00
SYM balance_sheet (annual, 2022-09-30) — Raw Materials: 88999000.00
SYM balance_sheet (annual, 2022-09-30) — Receivables: 105228000.00
SYM income_statement (annual, 2022-09-30) — Reconciled Cost Of Revenue: 493665000.00
SYM income_statement (annual, 2022-09-30) — Reconciled Depreciation: 5989000.00
SYM income_statement (annual, 2022-09-30) — Research And Development: 124141000.00
SYM balance_sheet (annual, 2022-09-30) — Retained Earnings: -1286569000.00
SYM cash_flow (annual, 2022-09-30) — Sale Of Investment: 0.00
SYM income_statement (annual, 2022-09-30) — Selling General And Administration: 115881000.00
SYM balance_sheet (annual, 2022-09-30) — Share Issued: 57718836.00
SYM cash_flow (annual, 2022-09-30) — Stock Based Compensation: 26858000.00
SYM balance_sheet (annual, 2022-09-30) — Stockholders Equity: 7184000.00
SYM balance_sheet (annual, 2022-09-30) — Tangible Book Value: 6534000.00
SYM income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: 0.00
SYM income_statement (annual, 2022-09-30) — Tax Provision: 0.00
SYM income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.00
SYM balance_sheet (annual, 2022-09-30) — Total Assets: 631263000.00
SYM balance_sheet (annual, 2022-09-30) — Total Capitalization: 7184000.00
SYM balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 68940000.00
SYM income_statement (annual, 2022-09-30) — Total Expenses: 733687000.00
SYM balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 562323000.00
SYM balance_sheet (annual, 2022-09-30) — Total Non Current Assets: 25865000.00
SYM balance_sheet (annual, 2022-09-30) — Total Non Current Liabilities Net Minority Interest: 39366000.00
SYM income_statement (annual, 2022-09-30) — Total Operating Income As Reported: -140375000.00
SYM balance_sheet (annual, 2022-09-30) — Total Tax Payable: 12953000.00
SYM balance_sheet (annual, 2022-09-30) — Working Capital: 82441000.00
SYM income_statement (annual, 2023-09-30) — +Operating Expense: 412969000.00
SYM income_statement (annual, 2023-09-30) — +Total Revenue: 1176891000.00
SYM balance_sheet (annual, 2023-09-30) — Accounts Payable: 109918000.00
SYM balance_sheet (annual, 2023-09-30) — Accounts Receivable: 69206000.00
SYM balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -18762000.00
SYM balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 1312148000.00
SYM cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 1835000.00
SYM cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 1835000.00
SYM income_statement (annual, 2023-09-30) — Basic Average Shares: 64338580.00
SYM income_statement (annual, 2023-09-30) — Basic EPS: -0.37
SYM cash_flow (annual, 2023-09-30) — Beginning Cash Position: 353457000.00
SYM cash_flow (annual, 2023-09-30) — Capital Expenditure: -21326000.00
SYM cash_flow (annual, 2023-09-30) — Capital Expenditure Reported: -5638000.00
SYM balance_sheet (annual, 2023-09-30) — Capital Stock: 56000.00
SYM balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 258770000.00
SYM balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Short Term Investments: 545506000.00
SYM cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: -24101000.00
SYM cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -299464000.00
SYM cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: 230794000.00
SYM cash_flow (annual, 2023-09-30) — Change In Account Payable: 41415000.00
SYM cash_flow (annual, 2023-09-30) — Change In Accrued Expense: 64743000.00
SYM cash_flow (annual, 2023-09-30) — Change In Inventory: -66380000.00
SYM cash_flow (annual, 2023-09-30) — Change In Other Current Assets: -18635000.00
SYM cash_flow (annual, 2023-09-30) — Change In Other Current Liabilities: 20073000.00
SYM cash_flow (annual, 2023-09-30) — Change In Other Working Capital: 356090000.00
SYM cash_flow (annual, 2023-09-30) — Change In Payable: 41415000.00
SYM cash_flow (annual, 2023-09-30) — Change In Payables And Accrued Expense: 106158000.00
SYM cash_flow (annual, 2023-09-30) — Change In Prepaid Assets: -78906000.00
SYM cash_flow (annual, 2023-09-30) — Change In Receivables: -65817000.00
SYM cash_flow (annual, 2023-09-30) — Change In Working Capital: 252583000.00
SYM cash_flow (annual, 2023-09-30) — Changes In Account Receivables: -65817000.00
SYM cash_flow (annual, 2023-09-30) — Changes In Cash: -92771000.00
SYM balance_sheet (annual, 2023-09-30) — Common Stock: 56000.00
SYM balance_sheet (annual, 2023-09-30) — Common Stock Equity: 82000.00
SYM cash_flow (annual, 2023-09-30) — Common Stock Issuance: 0.00
SYM income_statement (annual, 2023-09-30) — Cost Of Revenue: 987152000.00
SYM balance_sheet (annual, 2023-09-30) — Current Accrued Expenses: 128314000.00
SYM balance_sheet (annual, 2023-09-30) — Current Assets: 991795000.00
SYM balance_sheet (annual, 2023-09-30) — Current Deferred Assets: 34577000.00
SYM balance_sheet (annual, 2023-09-30) — Current Deferred Liabilities: 787227000.00
SYM balance_sheet (annual, 2023-09-30) — Current Deferred Revenue: 787227000.00
SYM balance_sheet (annual, 2023-09-30) — Current Liabilities: 1025459000.00
SYM cash_flow (annual, 2023-09-30) — Deferred Income Tax: -4620000.00
SYM cash_flow (annual, 2023-09-30) — Deferred Tax: -4620000.00
SYM cash_flow (annual, 2023-09-30) — Depreciation: 11311000.00
SYM cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 11311000.00
SYM cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 11311000.00
SYM income_statement (annual, 2023-09-30) — Diluted Average Shares: 64338580.00
SYM income_statement (annual, 2023-09-30) — Diluted EPS: -0.37
SYM income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -23866000.00
SYM income_statement (annual, 2023-09-30) — EBIT: -223230000.00
SYM income_statement (annual, 2023-09-30) — EBITDA: -211919000.00
SYM income_statement (annual, 2023-09-30) — Earnings From Equity Interest Net Of Tax: 0.00
SYM cash_flow (annual, 2023-09-30) — Earnings Losses From Equity Investments: 0.00
SYM cash_flow (annual, 2023-09-30) — Effect Of Exchange Rate Changes: 232000.00
SYM cash_flow (annual, 2023-09-30) — End Cash Position: 260918000.00
SYM cash_flow (annual, 2023-09-30) — Financing Cash Flow: -24101000.00
SYM balance_sheet (annual, 2023-09-30) — Finished Goods: 11675000.00
SYM cash_flow (annual, 2023-09-30) — Free Cash Flow: 209468000.00
SYM balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: -1687000.00
SYM balance_sheet (annual, 2023-09-30) — Goodwill And Other Intangible Assets: 217000.00
SYM balance_sheet (annual, 2023-09-30) — Gross PPE: 53269000.00
SYM income_statement (annual, 2023-09-30) — Gross Profit: 189739000.00
SYM balance_sheet (annual, 2023-09-30) — Inventory: 136121000.00
SYM balance_sheet (annual, 2023-09-30) — Invested Capital: 82000.00
SYM cash_flow (annual, 2023-09-30) — Investing Cash Flow: -299464000.00
SYM balance_sheet (annual, 2023-09-30) — Investments And Advances: 0.00
SYM balance_sheet (annual, 2023-09-30) — Investmentsin Joint Venturesat Cost: 0.00
SYM cash_flow (annual, 2023-09-30) — Issuance Of Capital Stock: 0.00
SYM balance_sheet (annual, 2023-09-30) — Leases: 7194000.00
SYM balance_sheet (annual, 2023-09-30) — Long Term Equity Investment: 0.00
SYM balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 46075000.00
SYM balance_sheet (annual, 2023-09-30) — Minority Interest: -2798000.00
SYM income_statement (annual, 2023-09-30) — Minority Interests: 184028000.00
SYM cash_flow (annual, 2023-09-30) — Net Business Purchase And Sale: 0.00
SYM cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: 0.00
SYM cash_flow (annual, 2023-09-30) — Net Foreign Currency Exchange Gain Loss: -3000.00
SYM income_statement (annual, 2023-09-30) — Net Income: -23866000.00
SYM income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -23866000.00
SYM income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -207894000.00
SYM income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -23866000.00
SYM income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -23866000.00
SYM cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -207894000.00
SYM income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -207894000.00
SYM cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: -278209000.00
SYM cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -26674000.00
SYM cash_flow (annual, 2023-09-30) — Net Other Investing Changes: 71000.00
SYM balance_sheet (annual, 2023-09-30) — Net PPE: 34507000.00
SYM cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -21326000.00
SYM balance_sheet (annual, 2023-09-30) — Net Tangible Assets: -135000.00
SYM balance_sheet (annual, 2023-09-30) — Non Current Deferred Liabilities: 0.00
SYM balance_sheet (annual, 2023-09-30) — Non Current Deferred Revenue: 0.00
SYM income_statement (annual, 2023-09-30) — Normalized EBITDA: -211919000.00
SYM income_statement (annual, 2023-09-30) — Normalized Income: -23866000.00
SYM cash_flow (annual, 2023-09-30) — Operating Cash Flow: 230794000.00
SYM cash_flow (annual, 2023-09-30) — Operating Gains Losses: 2911000.00
SYM income_statement (annual, 2023-09-30) — Operating Income: -223230000.00
SYM income_statement (annual, 2023-09-30) — Operating Revenue: 1176891000.00
SYM balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 82112881.00
SYM balance_sheet (annual, 2023-09-30) — Other Current Assets: 85236000.00
SYM balance_sheet (annual, 2023-09-30) — Other Equity Adjustments: -1687000.00
SYM income_statement (annual, 2023-09-30) — Other Income Expense: 10716000.00
SYM balance_sheet (annual, 2023-09-30) — Other Intangible Assets: 217000.00
SYM balance_sheet (annual, 2023-09-30) — Other Non Current Assets: 24191000.00
SYM balance_sheet (annual, 2023-09-30) — Other Non Current Liabilities: 27967000.00
SYM income_statement (annual, 2023-09-30) — Other Non Operating Income Expenses: 10716000.00
SYM balance_sheet (annual, 2023-09-30) — Other Receivables: 121149000.00
SYM balance_sheet (annual, 2023-09-30) — Other Short Term Investments: 286736000.00
SYM income_statement (annual, 2023-09-30) — Otherunder Preferred Stock Dividend: 0.00
SYM balance_sheet (annual, 2023-09-30) — Payables: 109918000.00
SYM balance_sheet (annual, 2023-09-30) — Payables And Accrued Expenses: 238232000.00
SYM income_statement (annual, 2023-09-30) — Pretax Income: -212514000.00
SYM cash_flow (annual, 2023-09-30) — Proceeds From Stock Option Exercised: 2573000.00
SYM balance_sheet (annual, 2023-09-30) — Properties: 0.00
SYM cash_flow (annual, 2023-09-30) — Provisionand Write Offof Assets: 22276000.00
SYM cash_flow (annual, 2023-09-30) — Purchase Of Business: 0.00
SYM cash_flow (annual, 2023-09-30) — Purchase Of Investment: -408209000.00
SYM cash_flow (annual, 2023-09-30) — Purchase Of PPE: -21326000.00
SYM balance_sheet (annual, 2023-09-30) — Raw Materials: 124446000.00
SYM balance_sheet (annual, 2023-09-30) — Receivables: 190355000.00
SYM income_statement (annual, 2023-09-30) — Reconciled Cost Of Revenue: 987152000.00
SYM income_statement (annual, 2023-09-30) — Reconciled Depreciation: 11311000.00
SYM income_statement (annual, 2023-09-30) — Research And Development: 195042000.00
SYM income_statement (annual, 2023-09-30) — Restructuring And Mergern Acquisition: 0.00
SYM balance_sheet (annual, 2023-09-30) — Retained Earnings: -1310435000.00
SYM cash_flow (annual, 2023-09-30) — Sale Of Investment: 130000000.00
SYM income_statement (annual, 2023-09-30) — Selling General And Administration: 217927000.00
SYM balance_sheet (annual, 2023-09-30) — Share Issued: 82112881.00
SYM income_statement (annual, 2023-09-30) — Special Income Charges: 0.00
SYM cash_flow (annual, 2023-09-30) — Stock Based Compensation: 154227000.00
SYM balance_sheet (annual, 2023-09-30) — Stockholders Equity: 82000.00
SYM balance_sheet (annual, 2023-09-30) — Tangible Book Value: -135000.00
SYM income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: 0.00
SYM income_statement (annual, 2023-09-30) — Tax Provision: -4620000.00
SYM income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.02
SYM balance_sheet (annual, 2023-09-30) — Total Assets: 1050710000.00
SYM balance_sheet (annual, 2023-09-30) — Total Capitalization: 82000.00
SYM balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: -2716000.00
SYM income_statement (annual, 2023-09-30) — Total Expenses: 1400121000.00
SYM balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 1053426000.00
SYM balance_sheet (annual, 2023-09-30) — Total Non Current Assets: 58915000.00
SYM balance_sheet (annual, 2023-09-30) — Total Non Current Liabilities Net Minority Interest: 27967000.00
SYM income_statement (annual, 2023-09-30) — Total Operating Income As Reported: -223230000.00
SYM balance_sheet (annual, 2023-09-30) — Total Tax Payable: 28322000.00
SYM income_statement (annual, 2023-09-30) — Total Unusual Items: 0.00
SYM income_statement (annual, 2023-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SYM balance_sheet (annual, 2023-09-30) — Treasury Shares Number: 0.00
SYM cash_flow (annual, 2023-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
SYM balance_sheet (annual, 2023-09-30) — Work In Process: 0.00
SYM balance_sheet (annual, 2023-09-30) — Working Capital: -33664000.00
SYM income_statement (annual, 2024-09-30) — +Operating Expense: 362391000.00
SYM income_statement (annual, 2024-09-30) — +Total Revenue: 1788179000.00
SYM balance_sheet (annual, 2024-09-30) — Accounts Payable: 175188000.00
SYM balance_sheet (annual, 2024-09-30) — Accounts Receivable: 201548000.00
SYM balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -34123000.00
SYM balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 1523692000.00
SYM cash_flow (annual, 2024-09-30) — Amortization Cash Flow: 2633000.00
SYM cash_flow (annual, 2024-09-30) — Amortization Of Intangibles: 2633000.00
SYM income_statement (annual, 2024-09-30) — Basic Average Shares: 95697368.00
SYM income_statement (annual, 2024-09-30) — Basic EPS: -0.08
SYM cash_flow (annual, 2024-09-30) — Beginning Cash Position: 260918000.00
SYM cash_flow (annual, 2024-09-30) — Capital Expenditure: -44374000.00
SYM cash_flow (annual, 2024-09-30) — Capital Expenditure Reported: -2137000.00
SYM cash_flow (quarterly, 2024-09-30) — Capital Expenditure Reported: -637000.00
SYM balance_sheet (annual, 2024-09-30) — Capital Stock: 60000.00
SYM balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 727310000.00
SYM balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 727310000.00
SYM cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: 371036000.00
SYM cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: 156481000.00
SYM cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: -58077000.00
SYM cash_flow (annual, 2024-09-30) — Change In Account Payable: 65270000.00
SYM cash_flow (annual, 2024-09-30) — Change In Accrued Expense: 38467000.00
SYM cash_flow (annual, 2024-09-30) — Change In Inventory: 103000.00
SYM cash_flow (annual, 2024-09-30) — Change In Other Current Assets: -9040000.00
SYM cash_flow (annual, 2024-09-30) — Change In Other Current Liabilities: -1189000.00
SYM cash_flow (annual, 2024-09-30) — Change In Other Working Capital: 13382000.00
SYM cash_flow (annual, 2024-09-30) — Change In Payable: 65270000.00
SYM cash_flow (annual, 2024-09-30) — Change In Payables And Accrued Expense: 103737000.00
SYM cash_flow (annual, 2024-09-30) — Change In Prepaid Assets: -112050000.00
SYM cash_flow (annual, 2024-09-30) — Change In Receivables: -132305000.00
SYM cash_flow (annual, 2024-09-30) — Change In Working Capital: -137362000.00
SYM cash_flow (annual, 2024-09-30) — Changes In Account Receivables: -132305000.00
SYM cash_flow (annual, 2024-09-30) — Changes In Cash: 469440000.00
SYM balance_sheet (annual, 2024-09-30) — Common Stock: 60000.00
SYM balance_sheet (annual, 2024-09-30) — Common Stock Equity: 197233000.00
SYM cash_flow (annual, 2024-09-30) — Common Stock Issuance: 257985000.00
SYM income_statement (annual, 2024-09-30) — Cost Of Revenue: 1542513000.00
SYM balance_sheet (annual, 2024-09-30) — Current Accrued Expenses: 165644000.00
SYM balance_sheet (annual, 2024-09-30) — Current Assets: 1355537000.00
SYM balance_sheet (annual, 2024-09-30) — Current Deferred Assets: 1058000.00
SYM balance_sheet (annual, 2024-09-30) — Current Deferred Liabilities: 676314000.00
SYM balance_sheet (annual, 2024-09-30) — Current Deferred Revenue: 676314000.00
SYM balance_sheet (annual, 2024-09-30) — Current Liabilities: 1017146000.00
SYM cash_flow (annual, 2024-09-30) — Deferred Income Tax: 3917000.00
SYM cash_flow (annual, 2024-09-30) — Deferred Tax: 3917000.00
SYM cash_flow (annual, 2024-09-30) — Depreciation: 23480000.00
SYM cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 23480000.00
SYM cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 23480000.00
SYM income_statement (annual, 2024-09-30) — Diluted Average Shares: 95697368.00
SYM income_statement (annual, 2024-09-30) — Diluted EPS: -0.08
SYM income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: -13490000.00
SYM income_statement (annual, 2024-09-30) — EBIT: -116725000.00
SYM income_statement (annual, 2024-09-30) — EBITDA: -93245000.00
SYM income_statement (annual, 2024-09-30) — Earnings From Equity Interest Net Of Tax: -777000.00
SYM cash_flow (annual, 2024-09-30) — Earnings Losses From Equity Investments: 777000.00
SYM cash_flow (annual, 2024-09-30) — Effect Of Exchange Rate Changes: -4000.00
SYM cash_flow (annual, 2024-09-30) — End Cash Position: 730354000.00
SYM cash_flow (annual, 2024-09-30) — Financing Cash Flow: 371036000.00
SYM balance_sheet (annual, 2024-09-30) — Finished Goods: 29319000.00
SYM cash_flow (annual, 2024-09-30) — Free Cash Flow: -102451000.00
SYM cash_flow (annual, 2024-09-30) — Gain Loss On Investment Securities: -10084000.00
SYM cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 0.00
SYM balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: -2594000.00
SYM balance_sheet (annual, 2024-09-30) — Goodwill: 0.00
SYM balance_sheet (annual, 2024-09-30) — Goodwill And Other Intangible Assets: 3664000.00
SYM balance_sheet (annual, 2024-09-30) — Gross PPE: 131232000.00
SYM income_statement (annual, 2024-09-30) — Gross Profit: 245666000.00
SYM balance_sheet (annual, 2024-09-30) — Inventory: 106136000.00
SYM balance_sheet (annual, 2024-09-30) — Invested Capital: 197233000.00
SYM cash_flow (annual, 2024-09-30) — Investing Cash Flow: 156481000.00
SYM balance_sheet (annual, 2024-09-30) — Investments And Advances: 81289000.00
SYM balance_sheet (annual, 2024-09-30) — Investmentsin Joint Venturesat Cost: 81289000.00
SYM balance_sheet (quarterly, 2024-09-30) — Investmentsin Joint Venturesat Cost: 81289000.00
SYM cash_flow (annual, 2024-09-30) — Issuance Of Capital Stock: 257985000.00
SYM balance_sheet (annual, 2024-09-30) — Leases: 9576000.00
SYM balance_sheet (annual, 2024-09-30) — Long Term Equity Investment: 81289000.00
SYM balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 121656000.00
SYM balance_sheet (annual, 2024-09-30) — Minority Interest: 192897000.00
SYM income_statement (annual, 2024-09-30) — Minority Interests: 71182000.00
SYM cash_flow (annual, 2024-09-30) — Net Business Purchase And Sale: 0.00
SYM cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: 257985000.00
SYM cash_flow (annual, 2024-09-30) — Net Foreign Currency Exchange Gain Loss: -8000.00
SYM income_statement (annual, 2024-09-30) — Net Income: -13490000.00
SYM income_statement (annual, 2024-09-30) — Net Income Common Stockholders: -13490000.00
SYM income_statement (annual, 2024-09-30) — Net Income Continuous Operations: -84672000.00
SYM income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: -13490000.00
SYM income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: -13490000.00
SYM cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: -84672000.00
SYM income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: -84672000.00
SYM cash_flow (annual, 2024-09-30) — Net Investment Purchase And Sale: 200855000.00
SYM cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -51396000.00
SYM balance_sheet (annual, 2024-09-30) — Net PPE: 97109000.00
SYM cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -44374000.00
SYM cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -20730000.00
SYM balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 193569000.00
SYM balance_sheet (annual, 2024-09-30) — Non Current Deferred Liabilities: 129233000.00
SYM balance_sheet (annual, 2024-09-30) — Non Current Deferred Revenue: 129233000.00
SYM income_statement (annual, 2024-09-30) — Normalized EBITDA: -93245000.00
SYM income_statement (annual, 2024-09-30) — Normalized Income: -13490000.00
SYM cash_flow (annual, 2024-09-30) — Operating Cash Flow: -58077000.00
SYM cash_flow (annual, 2024-09-30) — Operating Gains Losses: -8978000.00
SYM income_statement (annual, 2024-09-30) — Operating Income: -116725000.00
SYM income_statement (annual, 2024-09-30) — Operating Revenue: 1788179000.00
SYM balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 104689377.00
SYM balance_sheet (annual, 2024-09-30) — Other Current Assets: 101252000.00
SYM balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: -2594000.00
SYM income_statement (annual, 2024-09-30) — Other Income Expense: 37042000.00
SYM balance_sheet (annual, 2024-09-30) — Other Intangible Assets: 3664000.00
SYM balance_sheet (annual, 2024-09-30) — Other Non Current Assets: 40953000.00
SYM balance_sheet (annual, 2024-09-30) — Other Non Current Liabilities: 42043000.00
SYM income_statement (annual, 2024-09-30) — Other Non Operating Income Expenses: 37042000.00
SYM balance_sheet (annual, 2024-09-30) — Other Receivables: 218233000.00
SYM balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 0.00
SYM balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 0.00
SYM income_statement (annual, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
SYM balance_sheet (annual, 2024-09-30) — Payables: 175188000.00
SYM balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 340832000.00
SYM income_statement (annual, 2024-09-30) — Pretax Income: -79683000.00
SYM cash_flow (annual, 2024-09-30) — Proceeds From Stock Option Exercised: 164447000.00
SYM cash_flow (quarterly, 2024-09-30) — Proceeds From Stock Option Exercised: 2308000.00
SYM balance_sheet (annual, 2024-09-30) — Properties: 0.00
SYM cash_flow (annual, 2024-09-30) — Provisionand Write Offof Assets: 33330000.00
SYM cash_flow (annual, 2024-09-30) — Purchase Of Business: 0.00
SYM cash_flow (annual, 2024-09-30) — Purchase Of Investment: -139145000.00
SYM cash_flow (annual, 2024-09-30) — Purchase Of PPE: -44374000.00
SYM cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -20730000.00
SYM balance_sheet (annual, 2024-09-30) — Raw Materials: 72279000.00
SYM balance_sheet (annual, 2024-09-30) — Receivables: 419781000.00
SYM income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 1542513000.00
SYM income_statement (annual, 2024-09-30) — Reconciled Depreciation: 23480000.00
SYM income_statement (annual, 2024-09-30) — Research And Development: 173457000.00
SYM income_statement (annual, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
SYM balance_sheet (annual, 2024-09-30) — Retained Earnings: -1323925000.00
SYM cash_flow (annual, 2024-09-30) — Sale Of Investment: 340000000.00
SYM cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
SYM income_statement (annual, 2024-09-30) — Selling General And Administration: 188934000.00
SYM balance_sheet (annual, 2024-09-30) — Share Issued: 104689377.00
SYM income_statement (annual, 2024-09-30) — Special Income Charges: 0.00
SYM cash_flow (annual, 2024-09-30) — Stock Based Compensation: 112208000.00
SYM balance_sheet (annual, 2024-09-30) — Stockholders Equity: 197233000.00
SYM balance_sheet (annual, 2024-09-30) — Tangible Book Value: 193569000.00
SYM income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
SYM income_statement (annual, 2024-09-30) — Tax Provision: 4212000.00
SYM income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.21
SYM balance_sheet (annual, 2024-09-30) — Total Assets: 1578552000.00
SYM balance_sheet (annual, 2024-09-30) — Total Capitalization: 197233000.00
SYM balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 390130000.00
SYM income_statement (annual, 2024-09-30) — Total Expenses: 1904904000.00
SYM balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 1188422000.00
SYM balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 223015000.00
SYM balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 171276000.00
SYM income_statement (annual, 2024-09-30) — Total Operating Income As Reported: -116725000.00
SYM income_statement (annual, 2024-09-30) — Total Unusual Items: 0.00
SYM income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
SYM cash_flow (annual, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
SYM balance_sheet (annual, 2024-09-30) — Work In Process: 4538000.00
SYM balance_sheet (quarterly, 2024-09-30) — Work In Process: 4538000.00
SYM balance_sheet (annual, 2024-09-30) — Working Capital: 338391000.00
SYM cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: 0.00
SYM cash_flow (quarterly, 2024-12-31) — Depreciation: 7645000.00
SYM cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -7357000.00
SYM cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
SYM cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -7357000.00
SYM cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
SYM balance_sheet (quarterly, 2024-12-31) — Work In Process: 4435000.00
SYM income_statement (quarterly, 2025-03-31) — +Operating Expense: 131265000.00
SYM income_statement (quarterly, 2025-03-31) — +Total Revenue: 549651000.00
SYM balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 220027000.00
SYM balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 137562000.00
SYM balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -46883000.00
SYM balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1539378000.00
SYM income_statement (quarterly, 2025-03-31) — Basic Average Shares: 107726978.00
SYM income_statement (quarterly, 2025-03-31) — Basic EPS: -0.04
SYM cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 906086000.00
SYM cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -20560000.00
SYM cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -27917000.00
SYM balance_sheet (quarterly, 2025-03-31) — Capital Stock: 60000.00
SYM balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 954944000.00
SYM balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 954944000.00
SYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 2851000.00
SYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -220560000.00
SYM cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 269575000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 13806000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -65685000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Inventory: -23232000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -4836000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 2182000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 228526000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Payable: 13806000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -51879000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 90341000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Receivables: -3195000.00
SYM cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 237907000.00
SYM cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -3195000.00
SYM cash_flow (quarterly, 2025-03-31) — Changes In Cash: 51866000.00
SYM balance_sheet (quarterly, 2025-03-31) — Common Stock: 60000.00
SYM balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 205414000.00
SYM cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
SYM income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 438859000.00
SYM balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 166269000.00
SYM balance_sheet (quarterly, 2025-03-31) — Current Assets: 1497980000.00
SYM balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 4979000.00
SYM balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1086297000.00
SYM balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1086297000.00
SYM balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1472593000.00
SYM cash_flow (quarterly, 2025-03-31) — Depreciation: 12279000.00
SYM cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 12279000.00
SYM cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 12279000.00
SYM income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 107726978.00
SYM income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.04
SYM income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1804000.00
SYM income_statement (quarterly, 2025-03-31) — EBIT: -20473000.00
SYM income_statement (quarterly, 2025-03-31) — EBITDA: -8194000.00
SYM income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: -2490000.00
SYM cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 2491000.00
SYM cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 50000.00
SYM cash_flow (quarterly, 2025-03-31) — End Cash Position: 958002000.00
SYM cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 2851000.00
SYM balance_sheet (quarterly, 2025-03-31) — Finished Goods: 42626000.00
SYM cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 249015000.00
SYM balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2698000.00
SYM balance_sheet (quarterly, 2025-03-31) — Goodwill: 68669000.00
SYM balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 194462000.00
SYM balance_sheet (quarterly, 2025-03-31) — Gross PPE: 170589000.00
SYM income_statement (quarterly, 2025-03-31) — Gross Profit: 110792000.00
SYM balance_sheet (quarterly, 2025-03-31) — Inventory: 146281000.00
SYM balance_sheet (quarterly, 2025-03-31) — Invested Capital: 205414000.00
SYM cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -220560000.00
SYM balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 85323000.00
SYM cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
SYM balance_sheet (quarterly, 2025-03-31) — Leases: 10286000.00
SYM balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 85323000.00
SYM balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 160303000.00
SYM balance_sheet (quarterly, 2025-03-31) — Minority Interest: 216160000.00
SYM income_statement (quarterly, 2025-03-31) — Minority Interests: 8048000.00
SYM cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
SYM cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 20000.00
SYM income_statement (quarterly, 2025-03-31) — Net Income: -1804000.00
SYM income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1804000.00
SYM income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -9852000.00
SYM income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1804000.00
SYM income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1804000.00
SYM cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -9852000.00
SYM income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -9852000.00
SYM cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
SYM cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -382000.00
SYM balance_sheet (quarterly, 2025-03-31) — Net PPE: 123706000.00
SYM balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10952000.00
SYM balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 8152000.00
SYM balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 8152000.00
SYM income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -8194000.00
SYM income_statement (quarterly, 2025-03-31) — Normalized Income: -1804000.00
SYM cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 269575000.00
SYM cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 2511000.00
SYM income_statement (quarterly, 2025-03-31) — Operating Income: -20473000.00